<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib21">
 <label>21</label>
 <element-citation publication-type="journal" id="sbref210">
  <person-group person-group-type="author">
   <name>
    <surname>Trimble</surname>
    <given-names>CL</given-names>
   </name>
   <name>
    <surname>Morrow</surname>
    <given-names>MP</given-names>
   </name>
   <name>
    <surname>Kraynyak</surname>
    <given-names>KA</given-names>
   </name>
  </person-group>
  <article-title>Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial</article-title>
  <source>Lancet</source>
  <volume>386</volume>
  <year>2015</year>
  <fpage>2078</fpage>
  <lpage>2088</lpage>
  <pub-id pub-id-type="pmid">26386540</pub-id>
 </element-citation>
</ref>
